Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test. Data from the clinical study conducted in Europe on...
University of Cambridge spin-out company HexagonFab today announced a £1.9 million seed funding round, led by Cambridge Enterprise, joined by Parkwalk, New Grounds VC, Silicon Valley-based R42 Group, and several private investors.
The Government backed Knowledge Transfer Partnership (KTP) Programme has been supporting industry for over 40 years, embedding knowledge and technology to create more competitive and productive businesses.
The Government has annnounced its intention to intervene in the proposed acquisition of ARM with NVIDIA.
South Cambridgeshire businesses affected by the post-Christmas national lockdown can now apply online for the Government’s Restart Grants.
Cambridge cyclist, Rob Barber, completes 452 miles to raise money for The British Heart Foundation, Cancer Research UK, and Diabetes.
The Cambridge Index rose 326.2 points or 1.2% to close at 28,595.4, as five of the top ten Index heavyweights posted weekly gains to their share prices.
AccountAbility-Plus announces the launch of its latest service, The 300 Club. The 300 Club has been formed to support fledgling and ambitious business owners to grow their business.
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a new updated ‘seasonal scenario’ global demand analysis for COVID-19 vaccines.
In a world where everyone is competing to be the expert with their digital content to satisfy the needs and wants of search engines, how can a brand think differently to get ahead?
Johnson Matthey (JM), a global leader in sustainable technologies, today announces significant strategic developments in the commercialisation of eLNO – its portfolio of leading nickel rich advanced cathode materials – which put JM at the forefront of providing a sustainable and secure supply of cathode materials for customers, in line with its...
A series of articles by Tier 2 Consulting will help you install and configure an OpenShift cluster on Amazon Web Services (AWS).
With the help of Indie Cambridge - the community of ‘real’ Cambridge - Cambridge Network resumes its exploration of the best independent businesses, people, shops, cafés, restaurants, venues and events in Cambridge and the surrounding area. This week: Fen Ditton Gallery.
CRISPR offerings to enhance NUVISAN’s drug development service portfolio.
London, UK... Adaptate Biotherapeutics, a company focused on developing antibody-based therapeutics for modulation of gamma delta T cells, today announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million (circa. £13 million). This...
Early detection of cancer and improved survival rates will depend on development of more sensitive diagnostic methods.
In her regular series for Cambridge Network members - now in its 15th year - software training expert Karen Roem offers handy tips to help you 'Tame your computer'. This week she describes how to show your appointment page without opening your calendar (Microsoft Outlook).
Phico Therapeutics Ltd, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has been awarded a grant of up to $18.2 million USD (circa. £13.2 million GBP) from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global...
Leading British AI company Luminance has been selected for this year’s coveted Tech Nation Future Fifty programme which celebrates the UK’s most successful technology companies.
More than 3 million tests have now been processed at the Cambridge COVID-19 Test Centre as part of the University’s extensive response to the pandemic.